Joana B. Neves
Pond Street
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy.
Journal: Science advances
Published: June 12, 2026
Deciphering the phenotypic responses to 177Lu-based radioligand therapy to identify efficacious combinations.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 20, 2026
Organoids in parasitology: a game-changer for studying host-nematode interactions.
Journal: Parasitology
Published: July 22, 2025
Natural history of treated and untreated renal oncocytoma: a systematic review and meta-analysis.
Journal: BJU international
Published: July 07, 2025
Nephron Sparing Treatment (NEST) for small renal masses: understanding patients' and clinicians' experiences of a cohort-embedded randomised control trial.
Journal: Pilot and feasibility studies
Published: August 15, 2024
Identifying the facilitators and barriers to implementation of renal tumour biopsy in the diagnostic pathway for small renal masses.
Journal: BJU international
Published: July 23, 2024
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 15, 2023
Nephron Sparing Treatment (NEST) for Small Renal Masses: A Feasibility Cohort-embedded Randomised Controlled Trial Comparing Percutaneous Cryoablation and Robot-assisted Partial Nephrectomy.
Journal: European urology
Published: March 29, 2023
Epitheloid Angiomyolipomas of the Kidney: Rare Renal Tumors Associated With Poor Prognoses.
Journal: Urology
Published: January 05, 2023
POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cells.
Journal: Molecular cell
Published: June 06, 2022
Last Updated: 09/26/2026